Univariate analyses | Age– and sex–adjusted analyses | |||
---|---|---|---|---|
Variable | β valueb (95 % CI) | p Value | β valueb (95 % CI) | p Value |
Patients with SLE vs. HC | 46 (−17 to 110) | 0.151 | 44 (−24 to 112) | 0.205 |
Patients with SLE with SLEDAI-2 K ≥6 vs. HC | 147 (50–245) | 0.004 | 139 (34– 245) | 0.010 |
Patients with SLE with SLEDAI-2 K ≥6 vs. SLEDAI-2 K <6 | 153 (50–256) | 0.004 | 161 (54–267) | 0.004 |
Patients with SLE (categorical variables) | ||||
Any SLEDAI-2 K clinical features (yes vs. no) | 107.8 (8.1–207.4) | 0.035 | 108.4 (3.6–213.3) | 0.043 |
Neuropsychiatric clinical featuresa (yes vs. no) | −211.9 (−488.9 to 65.2) | 0.131 | −202.5 (−485.8 to 80.8) | 0.158 |
Vasculitisa (yes vs. no) | – | – | – | – |
Arthritisa (yes vs. no) | 48.3 (−87.7 to 184.2) | 0.480 | 46.0 (−94.4 to 186.4) | 0.514 |
Myositisa (yes vs. no) | – | – | – | – |
Renal featuresa (yes vs. no) | 265.2 (133.5–396.9) | <0.001 | 269.7 (135.9–403.5) | <0.001 |
Rasha (yes vs. no) | −2.1 (−144.6 to 140.4) | 0.977 | −9.1 (−154.9 to 136.6) | 0.901 |
Alopeciaa (yes vs. no) | −84.6 (−267.0 to 97.8) | 0.357 | −85.0 (−270.7 to 100.7) | 0.363 |
Mucosal ulcersa (yes vs. no) | – | – | – | – |
Serositisa (yes vs. no) | 231.1 (−160.4 to 622.6) | 0.242 | 216.6 (−187.5 to 620.7) | 0.287 |
Haematological featuresa (yes vs. no) | 20.4 (−212.5 to 253.3) | 0.861 | 9.1 (−231.3 to 249.5) | 0.940 |
Fevera (yes vs. no) | – | – | – | – |
Anti-dsDNA antibodies IF (positive vs. negative) | 115 (12–218) | 0.029 | 112 (3–221) | 0.044 |
Complement C3/C4 (low vs. normal) | −4 (−107 to 99) | 0.938 | −14 (−123 to 94) | 0.793 |
Anti-nucleosome antibodies (positive vs. negative) | 138 (38–238) | 0.008 | 131 (30–234) | 0.013 |
Patients with SLE (continuous variables) | ||||
SLEDAI-2 K | 14 (−1 to 29) | 0.061 | 14 (−1.5 to 30) | 0.074 |
cSLEDAI-2 K (only clinical SLEDAI-2 K items) | 16 (−1 to 33) | 0.060 | 16 (−1.0 to 34) | 0.065 |
C3, g/L | −9 (−209 to 192) | 0.931 | 5 (−205 to 216) | 0.958 |
C4, g/L | −232 (−695 to 230) | 0.319 | −210 (−694 to 273) | 0.386 |
Anti-nucleosome antibodies, U | −0.2 (−0.7 to 0.3) | 0.403 | −0.2 (−0.7 to 0.3) | 0.460 |
Anti-dsDNA antibodies, titre | 27 (−22 to 75) | 0.266 | 30 (−21 to 81) | 0.230 |
Urinary protein/creatinine ratio, mg/mmol | 270 (101–439) | 0.002 | 271 (98–444) | 0.003 |